ReNeuron | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

230 results for “ReNeuron”

Trials

View all 200 →

Active, not recruiting

Pilot Study of Mirtazapine for the Dual Tx of Depression and CINV in High-Grade Glioma Pts on TMZ

120 participants · First posted May 2, 2019

Phase II Study of Remeron for Cancer Patients Losing More Than 10% of Their Body Weight

13 participants · First posted Jan 30, 2009

Studying Motor Neuron Tests

47 participants · First posted Jan 25, 2012

Drugs

View all 10 →

CTX-derived exosomes (ReNeuron)

Human retinal progenitor cells (ReNeuron Ltd.)

Poly-YE vaccine (Proneuron)

Organizations

ReNeuron Ltd.

United Kingdom

RENEURON LIMITED

United Kingdom

GeNeuro SA

Switzerland

News

View all 15 →

Wales Launches £100 Million Life Sciences Hub to Boost Innovation and Investment

Exonate Appoints Olav Hellebø as CEO, Advances Topical VEGF Eye Drop Toward Phase IIb Trial

Exosome Therapeutics Field Advances Toward Clinical Trials as Industry Prepares for Regulatory Milestones

Page 1 of 23